MEI Pharma Offers New Clinical Data from First-in-Human Study of ME-401
April 20, 2016 at 08:03 AM EDT
MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced new ...